| Aug-16-18 08:00AM | Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins PR Newswire |
| Aug-14-18 08:00AM | Procleix® Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix® Panther® System PR Newswire |
| Aug-01-18 11:36AM | Healthcare firm Grifols S.A. wins US antitrust nod to buy Biotest US Corp Reuters |
| Jun-27-18 02:23AM | What is Behind Grifols SAs (BME:GRF) Superior ROE? Simply Wall St. |
| Jun-22-18 07:30AM | Free Technical Research on ImmunoGen and Three More Biotech Equities ACCESSWIRE |
| Jun-19-18 08:25AM | Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays PR Newswire |
| Jun-15-18 02:39PM | 2 Stable and 2 Speculative Biotech Stocks to Buy InvestorPlace |
| Jun-07-18 08:15AM | Factors of Influence in 2018, Key Indicators and Opportunity within Eldorado Gold, Lamar Advertising, Bitauto, Magellan Midstream Partners, Deutsche Bank Aktiengesellschaft, and Grifols, S.A. New Research Emphasizes Economic Growth GlobeNewswire |
| May-31-18 09:00AM | Grifols Launches a New Testing Service for Patients Treated with Daratumumab PR Newswire |
| May-25-18 01:46PM | Biotech and energy top list for best paying jobs Yahoo Finance Video |
| May-14-18 08:00AM | Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents PR Newswire |
| May-10-18 03:59AM | BRIEF-Boya Bio-Pharmaceutical Signs Agreement With Grifols S.A. To Set Up Blood Plasma Stations Reuters |
| Apr-27-18 02:43PM | Grifols, Novo expansions prompt $1.3M renovation of JoCo training center American City Business Journals |
| Apr-16-18 11:21AM | Grifols donates over 25 million international units of blood clotting factor in 2017 PR Newswire |
| Apr-13-18 06:19AM | With 21.50% Earnings Growth, Did Grifols SA. (BME:GRF) Outperform The Industry? Simply Wall St. |
| Apr-10-18 08:20AM | Report: Exploring Fundamental Drivers Behind Itau Unibanco Holding S.A, Weibo, Redhill Biopharma, Shenandoah Telecommunications, Grifols, S.A, and Orthofix International N.V New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire |
| Apr-06-18 10:40AM | Grifols 2017 Annual Report on Form 20-F filed with the SEC on April 6, 2018 PR Newswire |
| Mar-29-18 08:59AM | Estimating The Fair Value Of Grifols SA. (BME:GRF) Simply Wall St. |
| Mar-22-18 08:38AM | Is It Time To Buy Grifols SA. (BME:GRF) Based Off Its PE Ratio? Simply Wall St. |
| Mar-15-18 06:50AM | Can Grifols SA. (BME:GRF) Continue To Outperform Its Industry? Simply Wall St. |
| Mar-14-18 02:50PM | Grifols breaks ground on $120M Clayton facility American City Business Journals |
| Mar-13-18 08:00AM | Consolidated Research: 2018 Summary Expectations for B Communications, Student Transportation, Aurinia Pharmaceuticals, Grifols, S.A., NEXEO SOLUTIONS, and ASML Holding N.V. Fundamental Analysis, Key Performance Indications GlobeNewswire |
| Mar-06-18 09:42AM | Henry Schien to Distribute Grifols Product in United States Zacks |
| Mar-05-18 09:00AM | Grifols Announces New Agreement with Henry Schein to Distribute Normal Saline Solution in the U.S. PR Newswire |
| Feb-28-18 10:05AM | Grifols Shines Light on Rare Disease with Launch of Educational Campaign "Look Into Genetic COPD" PR Newswire |
| Feb-06-18 09:45AM | Grifols HyperRAB® (rabies immune globulin ) 300 IU/mL Receives FDA Approval to Treat Patients Exposed to Rabies Virus Infection PR Newswire |
| Jan-03-18 03:00AM | Stocks With Rising Relative Price Strength: Grifols Investor's Business Daily |
| Dec-19-17 01:09PM | ETFs with exposure to Grifols SA : December 19, 2017 Capital Cube |
| Dec-11-17 12:06PM | Grifols SA : GRFS-US: Dividend Analysis : December 04th, 2017 (record date) : By the numbers : December 11, 2017 Capital Cube |
| Dec-05-17 12:54PM | ETFs with exposure to Grifols SA : December 5, 2017 Capital Cube |
| Dec-04-17 08:00AM | Grifols Misterium® Cleanroom Solutions Expands to Include Revolutionary Decontamination Air and Surface Disinfection Systems for Pharmaceutical Preparation PR Newswire |
| Nov-16-17 11:39AM | ETFs with exposure to Grifols SA : November 16, 2017 Capital Cube |
| Nov-02-17 12:11PM | ETFs with exposure to Grifols SA : November 2, 2017 Capital Cube |
| Oct-31-17 03:00AM | Stocks Showing Rising Market Leadership: Grifols Earns 83 RS Rating Investor's Business Daily +5.35% |
| Oct-23-17 10:40AM | ETFs with exposure to Grifols SA : October 23, 2017 Capital Cube |
| Oct-10-17 11:29AM | ETFs with exposure to Grifols SA : October 10, 2017 Capital Cube |
| Oct-09-17 09:51AM | Grifols SA :GRFS-US: Earnings Analysis: Q2, 2017 By the Numbers : October 9, 2017 Capital Cube |
| Sep-20-17 09:30AM | Should Value Investors Consider Grifols (GRFS) Stock Now? Zacks |
| Sep-13-17 11:25AM | 3 Pharma/Biotech Sector Bargains for a Healthy Portfolio Zacks |
| Sep-06-17 03:00AM | Grifols Shows Market Leadership With Jump To 82 RS Rating Investor's Business Daily |
| Aug-29-17 12:31PM | Grifols Is a Leader in High-Demand Plasma GuruFocus.com |
| Aug-28-17 03:00AM | Stocks Flashing Renewed Technical Strength: Grifols Investor's Business Daily |
| Aug-22-17 08:00AM | Grifols Phocus Rx® Pharmacy Workflow Management Solution Now Integrates With Top Hospital Information Systems via HL7 Interfaces PR Newswire |
| Aug-01-17 08:00AM | Select American Red Cross Blood Donations Screened for Babesia Parasite Using Grifols' Procleix Babesia Assay Under an Investigational New Drug Protocol PR Newswire |
| Jun-22-17 03:11PM | Grifols Continues to Strengthen its Diagnostic Division by Launching New Global Testing Services for the Measurement of Biological Drug Levels and Anti-Drug Immune Response in Blood Samples PR Newswire |
| Jun-21-17 03:48PM | When 'New' Means A Stock Hasn't Led The Market In A While Investor's Business Daily |
| Jun-16-17 09:55AM | Should Value Investors Consider Grifols (GRFS) Stock Right Now? Zacks |
| Jun-12-17 04:00AM | Grifols and Beckman Coulter Enter into an Exclusive Distribution Agreement PR Newswire |
| May-31-17 11:02AM | Grifols SA : GRFS-US: Dividend Analysis : June 01st, 2017 (record date) : By the numbers : May 31, 2017 Capital Cube |
| May-10-17 04:45PM | Hologic Smashes Fiscal Q2 Sales Views, Beats On Profit By 4 Cents Investor's Business Daily |
| May-09-17 10:00AM | Investigational New Drug Application is Now Effective for Babesia Screening in Blood Donations Using Grifols Procleix Panther System in the US PR Newswire |
| May-04-17 10:37AM | VIVUS (VVUS) Loss Narrower than Expected, Revenues Up Y/Y Zacks |
| Apr-27-17 04:37PM | Glaxo (GSK) Reports In-Line Q1 Earnings, Reiterates View Zacks |
| 11:11AM | Celgene (CELG) Tops on Q1 Earnings, Sales Miss, Raises View Zacks |
| Apr-24-17 08:00AM | Grifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year Extension of OraSure Technologies Agreement and a New Manufacturing Facility PR Newswire |
| Apr-20-17 10:30AM | Nivalis' (NVLS) Shares Down After Merger Deal with Alpine Zacks |
| 08:15AM | GENOCEA BIOSCIENCES (GNCA) Catches Eye: Stock Gains 7.1% Zacks |
| Apr-19-17 02:06PM | How to Uncover Institutional Buying Zacks |
| 01:32PM | Can young blood pump new life into treatments for diseases of aging? American City Business Journals |
| Apr-17-17 09:00AM | Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Hemophilia Humanitarian Aid Program PR Newswire |
| Apr-05-17 11:20AM | Amgen Files for Xgeva Label Expansion, To Include Myeloma Zacks |
| 11:20AM | Amgen Files for Xgeva Label Expansion, To Include Myeloma |
| Apr-04-17 09:19AM | Sanofi's (SNY) Diabetes Drug Toujeo Lowers Hypoglycemia Risk Zacks |
| 09:11AM | Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017 PR Newswire |
| 09:11AM | Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017 |
| Apr-01-17 12:12PM | New Breakout Stocks Zacks Rank #1 (Strong Buy) Zacks |
| 12:12PM | New Breakout Stocks Zacks Rank #1 (Strong Buy) |
| Mar-31-17 08:41AM | AbbVie's (ABBV) Humira Drug Label Update Approved by FDA Zacks |
| 08:41AM | AbbVie's (ABBV) Humira Drug Label Update Approved by FDA |
| Mar-30-17 10:51AM | New Strong Buy Stocks for March 30th Zacks |
| 10:51AM | New Strong Buy Stocks for March 30th |
| Mar-28-17 08:15AM | Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2% Zacks |
| 08:15AM | Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2% |
| Mar-22-17 08:19AM | 5 Cheap PEG Picks for Value Investors Right Now |
| Mar-21-17 02:58PM | Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod Zacks |
| 02:58PM | Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod |
| Mar-20-17 10:32AM | AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal Zacks |
| 10:32AM | AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal |
| Mar-17-17 09:50AM | Is Grifols a Great Stock for Value Investors? |
| Mar-10-17 08:15AM | Aurinia (AUPH) Catches Eye: Stock Moves up 8.5% in Session |
| Mar-09-17 09:27AM | New Strong Buy Stocks for March 9th |
| 08:15AM | Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6% |
| Mar-07-17 05:48PM | 5 European Stocks to Buy as Trump Rally Weakens |
| Mar-06-17 12:24PM | Grifols SA :GRFS-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017 |
| Mar-03-17 10:46AM | Grifols SA :GRFS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017 |
| Mar-02-17 08:15AM | Blog Coverage Kite Pharma CAR-T Cancer Therapy Demonstrate Positive Results in B-cell non-Hodgkin Lymphoma Accesswire |
| Jan-31-17 04:05PM | Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million PR Newswire |
| 04:01PM | Hologic Completes Divestiture of Blood Screening Business PR Newswire |
| Jan-30-17 12:26PM | Grifols SA : GRFS-US: Dividend Analysis : December 07th, 2016 (record date) : By the numbers : January 30, 2017 |
| Jan-03-17 11:51AM | Grifols, S.A. upgraded by JP Morgan |
| Dec-19-16 07:46AM | Hologic (HOLX) to Divest Blood Screening Business to Grifols |
| Dec-15-16 04:42PM | Hologic Still A Buy After Getting 'Lofty' Price For Blood-Screening Unit +6.99% |
| Dec-14-16 07:14PM | Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B |
| 04:43PM | Hologic to sell stake in blood screening unit for $1.85 bln at MarketWatch |
| 04:15PM | Grifols agrees to acquire Hologic's share of NAT donor screening unit for USD 1,850 million PR Newswire |
| 04:01PM | Hologic to Divest Blood Screening Business to Partner Grifols for $1.85 Billion PR Newswire |
| Dec-13-16 12:56PM | ETFs with exposure to Grifols SA : December 13, 2016 |
| Dec-09-16 06:52PM | Virgin America Inc (VA): Is It Right For Your Portfolio? at Insider Monkey |
| Dec-05-16 06:45AM | Ligand Pharmaceuticals Inc. (LGND): Hedge Fund Sentiment Unchanged at Insider Monkey |
| Dec-02-16 12:29PM | ETFs with exposure to Grifols SA : December 2, 2016 |
|
|
|
| Grifols, S.A., a specialty pharmaceutical company, develops, manufactures, and distributes biological medicines on plasma derived proteins in the United States, Canada, Spain, rest of the European Union, and internationally. The company operates through five segments: Bioscience, Diagnostic, Hospital, Bio Supplies, and Others. The Bioscience segment manufactures plasma derivatives for therapeutic use, including the reception, analysis, quarantine, classification, fractionation, and purification of plasma; and sells and distributes end products. It offers plasma products, such as intravenous immune globulin, Factor VIII, alpha-1 proteinase inhibitor, and albumin; and intramuscular immunoglobulins, antithrombin III, Factor IX, and plasma thromboplastin components. The Diagnostic segment focuses on researching, developing, manufacturing, and marketing in vitro diagnostics products comprising analytical instruments, reagents, software, and related products for use in clinical and blood bank laboratories. It serves blood donation centers, clinical analysis laboratories, and hospital immunohematology services. The Hospital segment offers products used by hospitals, as well as parenteral solutions and enteral nutritional fluids. The Bio Supplies segment provides biological products for non-therapeutic uses. The Others segment renders manufacturing services to third party companies. The company also provides infusion solutions, nutrition products, and medical devices for use in hospitals and clinics; and engineering services. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves hospitals and clinics, group purchasing organizations, governments, and other distributors through sales representatives, marketing partners, and third-party distributors. Grifols, S.A. was founded in 1940 and is headquartered in Barcelona, Spain. |
